Lyell Immunopharma Inc
(LYEL)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 109,426 | 123,554 | 116,311 | 205,739 | 222,596 |
| Marketable Securities | 503,343 | 516,598 | 531,821 | 449,825 | 391,316 |
| TOTAL | $624,398 | $651,295 | $659,745 | $666,778 | $625,705 |
| Non-Current Assets | |||||
| PPE Net | 118,600 | 123,023 | 125,727 | 127,559 | 125,707 |
| Investments And Advances | 90,179 | 115,041 | 144,520 | 178,439 | 271,119 |
| Other Non-Current Assets | 47,273 | 48,202 | 47,277 | 48,898 | 49,572 |
| TOTAL | $256,052 | $286,266 | $317,524 | $354,896 | $446,398 |
| Total Assets | $880,450 | $937,561 | $977,269 | $1,021,674 | $1,072,103 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,733 | 3,917 | 4,795 | 4,247 | 6,510 |
| Accrued Expenses | 22,416 | 28,755 | 23,568 | 21,396 | 22,686 |
| Other current liabilities | 2,648 | 4,356 | 11,663 | 9,222 | 5,635 |
| TOTAL | $30,797 | $37,028 | $51,217 | $50,291 | $41,055 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 11,191 | 15,426 | 6,224 |
| Other Non-Current Liabilities | 65,827 | 67,281 | 68,863 | 70,414 | 71,928 |
| TOTAL | $65,827 | $67,281 | $106,026 | $103,341 | $149,799 |
| Total Liabilities | $96,624 | $104,309 | $157,243 | $153,632 | $190,854 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 12,480 | 12,480 | 12,466 | 12,391 | 12,307 |
| Common Shares | 25 | 25 | 25 | 25 | 25 |
| Retained earnings | -834,439 | -767,480 | -759,083 | -688,829 | -652,506 |
| Other shareholders' equity | -3,879 | -7,599 | -9,996 | -8,351 | -6,600 |
| TOTAL | $783,826 | $833,252 | $820,026 | $868,042 | $881,249 |
| Total Liabilities And Equity | $880,450 | $937,561 | $977,269 | $1,021,674 | $1,072,103 |